THERAPEUTICS

Labs from the Inflammation Research Center (VIB/UGent) are currently evaluating the effects of drugs to treat patients with respiratory illness associated with COVID-19.

On going studies

Sargramostim in Patients With Acute Hypoxic Respiratory Failure Due to COVID-19 (SARPAC)

Treatment of COVID-19 Patients With Anti-interleukin Drugs (COV-AID)